11 studies found for:    PRO-140 OR PRO-140[TREATMENT] AND HIV [CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
PRO-140 OR PRO-140[TREATMENT] AND HIV [CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection
Conditions: HIV;   Human Immunodeficiency Virus
Intervention: Drug: PRO 140 350mg weekly SQ injection.
2 Recruiting An Extension of Protocol PRO 140_CD01 TS Study
Conditions: HIV;   Human Immunodeficiency Virus
Intervention: Drug: PRO 140 350mg weekly SQ injection.
3 Active, not recruiting A Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination w/ Optimized Background Therapy in Treatment-Experienced HIV Subjects
Condition: HIV
Interventions: Drug: PRO 140;   Drug: Placebo;   Drug: Optimized Background Regimen
4 Completed
Has Results
PRO 140 by IV Administration in Adults With HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: PRO 140;   Drug: Placebo
5 Completed Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers
Condition: HIV Infections
Intervention: Drug: PRO 140
6 Completed
Has Results
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
Conditions: HIV -1 Infection;   HIV Infections
Interventions: Drug: PRO 140 (humanized monoclonal antibody to CCR5);   Drug: Placebo Comparator
7 Withdrawn PRO 140 for Human Immunodeficiency Virus Infection
Condition: HIV
Intervention: Biological: PRO 140
8 Recruiting PRO 140 for Human Immunodeficiency Virus
Condition: HIV
Intervention: Biological: PRO 140
9 Recruiting A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence
Condition: HIV
Interventions: Drug: PRO 140;   Drug: Placebo
10 Temporarily not available An Expanded Access Protocol for a Single Subject Who Has Completed 24-Weeks of Treatment in PR0140_CD02 Study
Condition: HIV
Intervention: Drug: PRO 140
11 Not yet recruiting Study of PRO 140 for Prophylaxis of Acute GVHD in Patients With AML or MDS Undergoing Allogeneic Stem-Cell Transplant.
Conditions: Graft vs Host Disease;   Leukemia, Myeloid, Acute;   Myelodysplastic Syndromes
Interventions: Drug: PRO 140;   Drug: Placebo

Indicates status has not been verified in more than two years